Study on the Correlation Between Iris Characteristics and Schizophrenia.

Background: Recently, researchers have conducted many studies on the potential contribution of the retina and other eye structures on schizophrenia. This study aimed to evaluate differences in iris characteristics between patients with schizophrenia and healthy individuals so as to find more easily accessible and easily measurable biomarkers with a view to improving clinical assessments and furthering our understanding of the disease.
Methods: Overall, 80 patients with schizophrenia and 52 healthy individuals were included in the case group and the control group, respectively. Iris images were collected from all subjects to compare differences in the structure and color of the iris. The Positive and Negative Symptom Scale (PANSS) and the Modified Overt Aggression Scale (MOAS) were used to evaluate the clinical symptoms and characteristics of 45 first-episode untreated schizophrenics, and analyzed correlations between iris characteristics and schizophrenia symptoms.
Results: There were significant differences in iris crypts (P<0.05) and pigment spots (P<0.01) between the case and control group, but no significant difference was found in iris wrinkles (P<0.05). The logistic regression analysis demonstrated that the total iris crypts [odds ratio (OR) 1.166, 95% confidence interval (CI) 1.022-1.330] and total iris pigment spots (OR 1.815, 95% CI 1.186-2.775) increased the risk of suffering from schizophrenia. Furthermore, it was demonstrated that the number of iris crypts was positively associated with the MOAS score (r=0.474, P<0.01). Moreover, the number of the iris pigment spots (r=0.395, P<0.01) and wrinkles (r=0.309, P<0.05) were positively correlated with the subjects' negative symptom scores, respectively.
Conclusion: Iris crypts and pigment spots were identified as potential biomarkers for detecting schizophrenia. In patients with first-episode untreated schizophrenia, iris characteristics may help psychiatrists to identify the illness and its severity, and to detect characteristic clinical symptoms.

Introduction

Schizophrenia has long been recognized as a severe psychiatric disease with high heritability, and it is one of the leading causes of global disease-related disability. According to the results of one epidemiological investigation, there are over 20 million cases of schizophrenia and the prevalence rate of worldwide around 1%.1 Additionally, the findings of another national epidemiological survey that was carried out in 31 provinces in China demonstrated that the life-time and 12-month prevalence rates of schizophrenia were the same, at 0.6% (95% CI: 0.1–1.0).2 As schizophrenia is associated with a series of severe clinical symptoms, such as fixed false beliefs, perceptual abnormalities, negative symptoms and cognitive deficits, patients with schizophrenia are at a higher risk of disability, recurrence, and a reduced quality of life, which ultimately shortens the entire life span.3 However, its underlying etiology and pathogenesis have not been fully explored. Biological, psychological, and social factors, such as genetic factors, intrauterine infection during pregnancy,4 early neurodevelopmental disorders, and psychological stress5,6 have been proven to be closely related to the development of schizophrenia. Moreover, there is considerable overlap of schizophrenia with other mental disorders, which means that early diagnosis proves difficult. Therefore, it is imperative to explore easily measurable biological indicators that could improve the early detection and early diagnosis of schizophrenia.

It is broadly accepted that the eyes and brain develop from the same layer (neural ectoderm), and many genes are implicated in both the eyes and normal neuronal development,7,8 such as Semaphorin 3A (SEMA3A),9 Paired box 6 (Pax6),10,11 SIX homeobox 3 (SIX3),12,13 HECT and RLD domain containing E3 ubiquitin protein ligase 2 (HERC2),14,15 and Oculocutaneous Albinism II (OCA2).16,17 Importantly, these genes are also related to schizophrenia and other mental disorders.9,18–22 The link between structural eye characteristics and psychiatric disorders has been increasingly confirmed in recent years.23 Systematic evaluation and meta-analyses have detected specific changes in the retinal structure of schizophrenic patients, who had thinner retinas and retinal blood vessels that were smaller in diameter compared with healthy people.24–27 Meanwhile, significant differences have also been observed between schizophrenic patients and healthy people in respect to pupil distance, corneal volume, anterior chamber volume, anterior chamber depth, and central corneal thickness.28

The human iris is the most specific tissue in the eye and its structure is characterized by8,14,29,30 crypts (defect of iris stroma), pigment spots, and wrinkles, as shown in Figure 1. Since 1956, studies have been carried out to examine the relationship between schizophrenia and iris color. For example, Kent et al31 found that among hospitalized schizophrenic patients, the mixed iris pigmentation patients accounted for the highest proportion. Compared with healthy people, Trixler et al32 found a higher rate of pigment spots, concentric furrows, and Wolfflin nodules in the iris structure of schizophrenic patients. He further speculated that a denser iris is expected more in healthy individuals, meaning low number of Fuchs crypts. However, as far as we know, very few studies have investigated the relationship between iris structure and schizophrenia, and the relationship between iris structure and psychotic symptoms in schizophrenia remains unclear. Thus, further research in this area is necessary.

Figure 1

Iris characteristics.

Subjects and Methods

Participants and Recruitment Procedure

The participants in this study included outpatients and inpatients from Shenyang Mental Health Center of Liaoning Province of China who were recruited between August 2019 and August 2020. The inclusion criteria were as follows: 1) aged between 18–60 years at the time of enrollment; 2) after independent assessments by two senior psychiatrists, participants were required to satisfy the diagnostic criteria for schizophrenia according to the Diagnostic and Statistical Manual for Mental Disorders-5 (DSM-5); 3) there was no kin relationship between subjects in the case group; 4) patients with other neuropsychiatric disorders and eye diseases (eg, iritis, glaucoma, and diabetes) were excluded; 5) the length of education is more than 9 years; 6) the patients or their guardians were able to liaise with the psychiatrists to complete the consultation, eye photography, and questionnaire survey; and 6) the patients or their guardians volunteered to participate in the study and provided their written informed consent.

In addition, 52 healthy subjects with no mental disorders, or neurological or physical diseases were age- and gender-matched with the schizophrenic patients. All participants completed a face-to-face interview to exclude psychiatric disorders. Moreover, all participants had a negative personal and family history of mental illness.

Principles of Ethical Review

This research was carried out in accordance with the Declaration of Helsinki. All participants were informed of the purpose, experimental methods, benefits and risks of the experiment, and their rights as participants in the experiment. The researchers obtained the written informed consent of all participants after a detailed explanation of the study was provided. This study was approved by the Ethics Committee of China Medical University (approval No. [2020] 2020-352-2).

Measurements

Iris Characteristics

For all participants, iris photographs were taken in the same ophthalmic examination room. Two ophthalmologists used Iris Image Collector EH–9100 (Yiheng Electronics Co., Ltd. Dongguan, China) to capture images of the iris.

The surface characteristics of the iris were counted by two senior ophthalmologists. Based on the findings of previous studies on genes related to iris structure and color, our study mainly classified iris characteristics as crypts, wrinkles, and pigment spots, as shown in Figure 1.

Iris Characteristics Statistical Method

The rotating coordinate statistics method was used to assess the iris characteristics consistently. As shown in Figure 2, this method takes the pupil center as the origin and makes two vertical intersection lines, so that the rectangular coordinate axis is formed by the iris boundary. Considering when iris is divided with a fixed rectangular coordinate axis, it is inevitable that a feature will be exactly divided in the quadrants on both sides by the vertical line, resulting in more statistical quadrants than the actual ones, as shown in Figure 2. To avoid the above situation, the vertical coordinate axis shall be rotated and adjusted with the origin as the center, and the iris should be divided into four quadrants with equal area but not fixed. Only when the vertical coordinate rotates no matter how, the quadrants involved in the iris characteristics are greater than 1, or greater than 2, or greater than 3, can it be counted as 2, or 3, or 4. That is, actually count the minimum number of quadrants involved in each characteristic (not the number of iris characteristics themselves), and then add the number of left and right iris statistics to mark the total frequency of iris characteristics.

Figure 2

Iris characteristic statistical method.

An example of statistical method is shown in Table 1, Figure 3.

Table 1

Number of Total Iris Characteristics

Iris Characteristic	Number of Quadrants Occupied		Total Number of Quadrants For Each Characteristic
	Left Iris	Right Iris
Crypt	0	2	2
Spot	2	0	2
Wrinkle	3	0	3

Notes: The number of total iris crypts, total iris pigment spots, and total iris wrinkles represents the sum of the number of quadrants occupied by the left iris and right iris, respectively.

Figure 3

Example for Iris characteristic statistical method.

Clinical Measurements

The Positive and Negative Symptom Scale (PANSS) is mainly used to assess the development of psychiatric symptoms in adults, and the severity of each symptom. The PANSS also distinguishes between positive symptoms and negative symptoms.33 It consists of 30 items, of which seven items are related to positive symptoms, seven items to negative symptoms, and 16 items to general psychopathology. Each item is rated according to a Likert-type scale ranging from 1 (none) to 7 (extremely severe). The entire assessment takes approximately 30 to 50 minutes to complete. By calculating the sum of the ratings of each item, we obtained the score for each subscale, which ranged from 7–49 for the positive and negative subscales, and 16–112 for the general psychopathology subscale.

The Modified Overt Aggression Scale (MOAS) was used to evaluate aggressive and violent behavior. It consists of four subscales which include verbal aggression, aggression against objects, physical aggression against oneself, and physical aggression against others. Each subscale measures the level of impulsive behavior according to a five-point Likert scale ranging from 0 (non-impulsive behavior) to 4 (the most severe impulsive performance). This scale has been proven to have better reliability and validity in the Chinese population.34

Statistical Analysis

The statistical analyses were performed using SPSS version 25.0 (SPSS Inc., Chicago). Independent samples t-tests and chi-square tests were conducted to compare demographic variables between patients and controls. For iris characteristics, the Mann–Whitney U-test was carried out to compare the significance of differences found between the two groups. Moreover, bivariate logistic regression analyses were performed to assess the association between the outcome variable (whether or not subjects developed schizophrenia), and potential predictors (eg, demographic characteristics, number of iris crypts and pigment spots). Taking the occurrence of schizophrenia as the dependent variable, demographic characteristics were used to predict the correlation between iris characteristics and schizophrenia. In the first-episode untreated schizophrenia group, the relationship between the PANSS, MOAS, and the total frequencies of iris characteristics were respectively analyzed using Spearman correlation analysis. All of these tests were two-tailed, and the level of statistical significance was set as P < 0.05.

Results

The sample size of the case group included 80 patients with schizophrenia who were recruited from the Shenyang Mental Health Center. As shown in Table 2, the subjects comprised 28 males (35.0%) and 52 females (65.0%) with a mean age of 38.85 (SD = 12.00) years, ranging from 18- to 60-years-old. The case group included 45 first-episode untreated patients, namely, 18 males and 27 females with a mean age of 29.87 (SD = 7.32, range: 18–43 years). A further in-depth analysis demonstrated that there was no kin relationship between the subjects in the case group. In addition, 52 healthy subjects of Chinese Han ethnicity (aged 18–58 years) were enrolled in the control group, and these subjects included 18 males and 34 females with a mean age of 40.37 (SD = 11.33) years. Moreover, as shown in Table 2, there was no significant difference in the mean age between the case group and healthy controls (P>0.05), and the chi-square test revealed no significant difference in gender between schizophrenic patients and controls (P>0.05). The male-to-female ratio in the schizophrenia group and control group was 28:52 and 18:34, respectively.

Table 2

Demographics of Case Group and Healthy Control Group

Factors	Healthy Control	Case Group	P
Age (Mean ± SD)	40.37±11.33	38.85±12.00	0.470a
Gender
Male	18	28	0.964b
Female	34	52

Note: “a” presents Student’s t-test analysis; “b” presents chi-square analysis.

Table 3 shows that iris crypts were found in 39 patients, 33 patients had iris pigment spots, and 27 patients had iris wrinkles. In the control group, iris crypts were observed in 14 patients, seven patients had iris pigment spots, and 11 patients had iris wrinkles. The distribution of iris crypts was significantly different between the two groups (P<0.05). A significant difference was also found in iris pigment spots between the two groups (P<0.01). There was no significant difference in iris wrinkles between the two groups (P>0.05).

Table 3

Iris Characteristics of Healthy Control Group (N=52) and Case Group (N=80)

Whether Have Iris Character	Number of Subjects		P
	Healthy Control Group	Case Group
Have crypts/Not	14/38	39/41	0.013a
Have pigment spots/Not	7/45	33/47	0.001a
Have wrinkles/Not	11/41	27/53	0.120a

Note: “a” presents the Mann–Whitney U-test.

As shown in Table 4 the number of iris crypts was positively correlated with MOAS scores, and the correlation coefficient was 0.474 (P<0.01); the number of iris pigment spots was positively correlated with negative symptom scores, and the correlation coefficient was 0.395 (P<0.01); the number of iris wrinkles was positively correlated with negative symptom scores, the correlation coefficient was 0.309 and P was<0.05. As illustrated in Figure 4, iris crypts (OR 2.465, 95% CI 1.126–5.397) and iris pigment spots (OR 4.356, 95% CI 1.725–11.003) were closely associated with the risk of contracting schizophrenia. Moreover, as shown in Table 5, the regression analysis revealed that increasing iris crypt and pigment spot grade increased the odds of contracting schizophrenia by 1.166 and 1.815, respectively.

Table 4

Correlations Between PANSS, MOAS, and the Total Frequencies of Each Iris Characteristics in Case Group (N=45)

Variable	Total Iris Crypts		Total Iris Spots		Total Iris Wrinkles
	r	P	r	P	r	P
PANSS score	−0.056	0.713	0.128	0.402	−0.068	0.656
Positive symptom score	−0.183	0.229	−0.136	0.371	−0.256	0.089
Negative symptom score	−0.087	0.57	0.395	0.007**	0.309	0.039*
General symptom score	0.169	0.268	−0.091	0.551	−0.164	0.280
MOAS score	0.474	0.001**	0.102	0.504	0.002	0.989

Note: “r” represents the correlation coefficient. *P<0.05; **P<0.01.

Figure 4

Correlation between iris characteristics and schizophrenia.

Table 5

Total Number of Iris Characteristics and the Risk of Schizophrenia

Variables	B	S.E.	Wals	OR (95% CI)	P
Total crypts	0.154	0.067	5.232	1.166 (1.022–1.330)	0.022
Total pigment spots	0.596	0.217	7.556	1.815 (1.186–2.775)	0.006

Notes: Binary regression analysis was performed to predict the total number of iris characteristics and the risk of schizophrenia. Illness presence was taken as the dependent variable. Measured covariates included the number of quadrants occupied by iris crypts and pigment spots, respectively.

Discussion

This study carried out a comparison of iris surface features between schizophrenics and healthy individuals, and analyzed the correlation between iris characteristics and the severity of symptoms, particularly with regard to impulsive behavior in patients with first-episode untreated schizophrenia. The results revealed significant differences in the frequency of iris crypts and pigment spots between the case group and healthy controls, which was consistent with the findings of Daniel Trixler et al.32 In other words, the frequency of pigment spots was higher in schizophrenic patients than in healthy controls. However, no significant correlation was found between iris wrinkles and subjects in the case group or the control group. This finding may be attributed to ethnic differences. For instance, Edwards et al30 found that the distribution of iris wrinkles was similar among individuals of South Asian and European ancestry, whereas those of East Asian ancestry had significantly fewer iris wrinkles than those of South Asian and European ancestry. In addition, compared with healthy controls, a higher quantity of iris crypts was detected in the case group. The results of the logistic regression analysis showed that the total number of iris crypts and pigment spots was associated with an increased risk of schizophrenia. Although the exact mechanism of these phenomena is unclear, we speculated that these phenomena may be related to polymorphisms in genes that regulate both eye and brain developments, such as Pax6, Six3, and Sema3A, and the mutation of these genes can lead to brain abnormalities.7 Furthermore, the pathological changes in the iris and brain are parallel:32 who had crypts on their iris, the brain MRI detected abnormal gray matter structure in the anterior cingulate gyrus, cerebellum, and middle temporal lobe.35–38 Similarly, Heyman et al21 found a higher incidence of mental illness and more obvious behavioral abnormalities in individuals with ocular structural abnormalities. The findings of Dou-dou Chen et al39 further confirmed the association between patients with intellectual disabilities and iris defects. The aforementioned theory and research results provide solid theoretical support for the link between schizophrenia and specific iris characteristics which are different to those observed in healthy individuals. Therefore, part of our findings could be explained in terms of a neurodevelopmental perspective.

Moreover, in first-episode untreated schizophrenic patients, iris crypt quantity was positively correlated with MOAS scores, and the frequency of iris pigment spots and wrinkles was positively correlated with negative symptom scores, as shown in Table 5. Previous studies which were not consistent with the results of our study have shown that iris crypts in healthy people were significantly correlated with emotional characteristics, while concentric furrow frequency was positively correlated with impulsivity.40 Thus far, few studies have been carried out to examine the relationship between iris characteristics and mental and behavioral symptoms in schizophrenic patients. However, in these patients, psychotic symptoms, emotional responses, and behavioral traits are associated with neurotransmitters such as dopamine and 5-hydroxytryptamine.41 Meanwhile, considering the correlation between the iris and brain structure, we therefore speculated that iris crypts, pigment spots, and iris wrinkles may be constitute an external manifestation of abnormalities in neurotransmitters and/or in the neural pathways of the brain. In other words, in schizophrenic patients, a higher number of iris crypts indicates a greater tendency towards aggressive behavior.

Lan Kent et al31 found that schizophrenic patients with mixed iris color accounted for the highest proportion of hospitalized schizophrenic patients. Iris color is determined by the concentration of melanin and melanocytes in its tissues,42 and mixed iris color is largely due to the uneven distribution of melanocytes, which also results in the formation of pigment spots on the iris. Additionally, many studies have found that some genes, such as HERC215 and OCA2, are related to both iris color and neural development. HERC2 is a giant E3 ubiquitin protein ligase that is associated with DNA repair regulation,43 pigmentation, and nervous system diseases15,21,44 such as schizophrenia, autism,45 and Down Syndrome.46 OCA2 is not only one of the major pigmentation genes affecting the quantity and quality of melanin in melanocytes, but it is also an independent factor that affects eye color.47 In addition, HERC2 can also regulate the expression of OCA2,48,49 which further affects eye pigmentation. The results of this study also found that first-episode untreated schizophrenic patients who had a higher frequency of iris pigment spots exhibited more prominent negative symptoms. This phenomenon is partly consistent with Lan Kent50 who found that, for assessment purposes, iris pigment spots can be reliable indicators of an individual’s physical and psychological characteristics: schizophrenics with light iris color exhibited paranoid traits, and the study categorized schizophrenics according to the concentration of iris pigmentation. The findings revealed that, as the pigmentation of the iris changes from light to dark, psychotic symptoms also change, manifesting in the form of prominent negative symptoms rather than prominent positive symptoms. In summary, we speculated that HERC2/OCA2 polymorphism may be one of the reasons that a higher incidence of iris pigment spots was detected in schizophrenic patients than in healthy controls. More importantly, it is possible that an excessive incidence of iris pigment spots can be used as an in vitro marker of abnormal brain function.

Limitations

There are several limitations to consider in the current study. First, we developed a novel statistical method to classify the structure of the iris. However, this technique has not been applied to larger study samples to clarify the advantages and disadvantages of this method, and to identify any shortcomings. Second, although there is a large body of evidence to support our reasoning, further genetic research is needed to verify our findings. Third, it was not possible to determine the effect that antipsychotics could have on the structure and color of the iris. Therefore, this paper presented an exploratory study regarding the relationship between schizophrenia and iris characteristics.

Conclusion

In summary, our study further supported the theory of neurodevelopmental disorders in the etiology of schizophrenia by demonstrating a link between specific iris structural features and schizophrenia. Moreover, we recommend that iris crypts and pigmentation spots be used as potential biomarkers to detect schizophrenia, which can help to identify new research directions for risk assessment, and improve early diagnosis and treatment in clinical practice.